ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Breast Cancer

Prostate Cancer trials near Seattle, WA, USA:

A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.

A first-in-human clinical trial to test the investigational treatment ONCT-534 in participants with metastatic castration-resistant prostate ...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: ONCT-534

Phase 1, Phase 2

Oncternal Therapeutics

Seattle, Washington, United States and 6 other locations

The purpose of this trial is to investigate the safety and tolerability of TAS3681, to find the maximum tolerated dose (MTD)/recommended dose of TAS3...

Active, not recruiting
Metastatic Castration Resistant Prostate Cancer
Drug: TAS3681

Phase 1

Taiho Pharma
Taiho Pharma

Seattle, Washington, United States and 33 other locations

androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...

Active, not recruiting
Prostate Cancer
Drug: Placebo oral tablet
Drug: Luteinizing Hormone-Releasing Hormone Analog

Phase 3

University of Sydney

Seattle, Washington, United States and 92 other locations

purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: BMS-986460

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Seattle, Washington, United States and 7 other locations

inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Drug: Pembrolizumab

Phase 2

VA Office of Research and Development
VA Office of Research and Development

Seattle, Washington, United States and 11 other locations

Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...

Enrolling
Prostate Cancer
Drug: Enzalutamide
Drug: AMG 509

Phase 1

Amgen
Amgen

Seattle, Washington, United States and 43 other locations

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a ...

Active, not recruiting
Prostate Cancer
Biological: Aglatimagene besadenovec + valacyclovir
Biological: Placebo + valacyclovir

Phase 3

Candel Therapeutics

Gig Harbor, Washington, United States and 72 other locations

of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Biological: vudalimab monotherapy
Combination Product: vudalimab + olaparib

Phase 2

Xencor
Xencor

Seattle, Washington, United States and 16 other locations

study to assess the safety and tolerability of ARX517 as monotherapy or in combination in adult subjects with Metastatic castration-resistant prostate...

Enrolling
Prostate Cancer
Drug: Enzalutamide
Drug: ARX517

Phase 1, Phase 2

Ambrx

Seattle, Washington, United States and 8 other locations

open-label clinical trial of the VTP-850 prime-boost immunotherapeutic in men with biochemical recurrence after definitive local therapy for prostate...

Enrolling
Prostate Cancer
Biological: ChAdOx1-PCAQ
Biological: MVA-PCAQ

Phase 1, Phase 2

Vaccitech

Seattle, Washington, United States and 9 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems